Hüser Norbert, Tertilt Christine, Gerauer Klaus, Maier Stefan, Traeger Tobias, Assfalg Volker, Reiter Rudolf, Heidecke Claus-Dieter, Pfeffer Klaus
Department of Surgery, Technische Universität München, Munich, Germany.
Eur J Immunol. 2005 Jan;35(1):128-38. doi: 10.1002/eji.200324745.
Chronic graft rejection mediated by cellular immune responses still poses a serious clinical problem in transplant surgery. Chemokines coordinate the recruitment of leukocytes in inflammatory and immune responses. Their precise functions in the rejection of allografts are still ill defined. This study investigates the role of chemokine receptor 4 (CCR4) in acute and chronic cardiac allograft rejection in mice. Allogeneic hearts were transplanted into CCR4 deficient (CCR4(-/-)) and control recipients. Reverse transcription-PCR showed transcription of macrophage-derived chemokine and thymus and activation-regulated chemokine, the cognate chemokine ligands of CCR4, within the graft. Compared to wild-type controls, acute allograft rejection in CCR4(-/-) recipients was only slightly prolonged. In contrast, in a gallium nitrate chronic cardiac allograft rejection model, cardiac graft survival was significantly prolonged in CCR4(-/-) recipients. A relative increase in the percentage of graft infiltrating CD8(+) T cells in CCR4(-/-) recipients was observed 30 days after transplantation and was accompanied by a decrease in CD4(+) T cells. Moreover, the percentage of NK1.1(+)CD3(+) graft-infiltrating cells was significantly reduced on day 5 and day 30 post transplantation. These findings indicate that CCR4 is involved in the recruitment of NK1.1(+)CD3(+) cells into cardiac allografts and clearly establish an important and novel role for CCR4 in chronic graft rejection.
由细胞免疫反应介导的慢性移植排斥反应在移植手术中仍然是一个严重的临床问题。趋化因子在炎症和免疫反应中协调白细胞的募集。它们在同种异体移植排斥反应中的精确功能仍不清楚。本研究调查趋化因子受体4(CCR4)在小鼠急性和慢性心脏移植排斥反应中的作用。将同种异体心脏移植到CCR4缺陷(CCR4(-/-))受体和对照受体中。逆转录聚合酶链反应显示移植体内CCR4的同源趋化因子配体——巨噬细胞衍生趋化因子和胸腺与激活调节趋化因子的转录。与野生型对照相比,CCR4(-/-)受体中的急性移植排斥反应仅略有延长。相比之下,在硝酸镓慢性心脏移植排斥反应模型中,CCR4(-/-)受体的心脏移植存活时间显著延长。移植后30天观察到CCR4(-/-)受体中移植浸润CD8(+) T细胞百分比相对增加,并伴有CD4(+) T细胞减少。此外,移植后第5天和第30天,NK1.1(+)CD3(+)移植浸润细胞的百分比显著降低。这些发现表明CCR4参与NK1.1(+)CD3(+)细胞向心脏同种异体移植物中的募集,并明确确立了CCR4在慢性移植排斥反应中的重要新作用。